Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Diagnostic Tests and Controls
  4. Flu and Virus Testing
  5. COVID Testing Kits
  6. 23222112

OraSure Technologies InteliSwab™ COVID-19 Rapid Test Pro Visual Reference Panel

Intended to assist new operators in becoming proficient at reading specimens with antigen levels near limit of detection of the device

Supplier:  OraSure Technologies 10010599

Catalog No. 23-222-112


Add to Cart

Description

Description

  • Comprised of InteliSwab™ COVID-19 Rapid Test Pro devices that have been designed to represent reading intensities of limit of detection, low positive and negative test results
  • Kit contains:
    • Instructions for use (IFU)
    • Foil pouch with:
      • One COVID-19 limit of detection device
      • One COVID-19 low positive device
      • One COVID-19 negative device
Specifications

Specifications

FDA EUA
Waived
Practice reading specimens with antigen levels near the limit of detection
Instructions for use, COVID-19 limit of detection device, COVID-19 low positive device, COVID-19 negative device
No
Visual Reference Panel
InteliSwab™ COVID-19 Rapid Test Pro
Kit
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.